The sections below cover what the pattern is, which numbers define it, why it shifts between tests, and when it is worth a conversation with a clinician.
Triglycerides are the main fat carried in blood, packaged inside lipoproteins and reported in mg/dL on a standard lipid panel drawn from a vein. They rise after meals, move quickly in response to alcohol and carbohydrate intake, and vary more from day to day than cholesterol does. In this pattern they represent one of the two axes, the fat side, while cholesterol measures represent the other. For the full detail on what the marker measures, how the test is run and what a single value may reflect, the Triglycerides guide covers it. Everything else on this page is about the pattern the two sides form together.
Mixed hyperlipidemia is a lab finding in which cholesterol measures and triglycerides are both above their standard reference ranges in the same person. You may see it written as combined hyperlipidemia, mixed dyslipidemia or, on a problem list, as a diagnostic code. All of those names point at the same thing, a two sided lipid picture rather than a single raised number.
It helps to see where both numbers come from. The liver packages triglycerides and cholesterol together inside lipoproteins, and each of those particles carries one copy of a structural protein called apolipoprotein B. When the liver releases more of these particles than usual, or when the bloodstream clears them more slowly, the fat carried inside them and the cholesterol carried inside them both climb. That is why the two numbers so often rise as a pair rather than independently.
Research suggests that overproduction of apolipoprotein B containing lipoproteins by the liver, combined with slower clearance, is a core feature of the inherited form of this pattern, familial combined hyperlipidemia 1. Studies indicate that the same production and clearance imbalance helps explain why the cholesterol side and the triglyceride side move together in affected families 2.
The practical consequence is that the label is a starting point, not an answer. It says what the blood looks like. It does not say why, and it does not on its own say what should happen next. Those questions belong to a clinician who can see the rest of the picture, including family history, weight trend, blood pressure, blood sugar handling and thyroid, liver and kidney function.
The difference is that two independent axes are off instead of one, and that changes how the blood looks at the particle level. Isolated high LDL cholesterol usually describes cholesterol rich particles accumulating, often because clearance from the bloodstream is slow. Mixed hyperlipidemia describes something broader, more circulating particles overall, each one carrying a different mix of fat and cholesterol.
That distinction matters for how a lipid panel reads. When triglycerides are high, the cholesterol tends to redistribute into particles that are smaller and denser, and HDL cholesterol often sits lower at the same time. In that setting, a calculated LDL cholesterol value can understate how many atherogenic particles are actually present, because the calculation assumes a typical relationship between fats and cholesterol inside those particles that high triglycerides disturb.
This is the reason clinicians working with a mixed picture often look past LDL cholesterol alone. Non-HDL cholesterol captures the cholesterol inside every atherogenic particle class in one number, and apolipoprotein B counts the particles themselves. A person with a mixed pattern and a reassuring LDL cholesterol value can still have a high particle count, and only the broader markers will show it.
So the honest summary is that high cholesterol alone and a mixed pattern are not two points on the same scale. They are different shapes of lipid biology, and the mixed shape typically needs more than one number to describe it accurately.
In everyday use, yes, mixed hyperlipoproteinemia and mixed hyperlipidemia describe the same pattern, with the longer word pointing at the particles rather than the fats. Hyperlipidemia refers to raised lipids in blood, meaning cholesterol and triglycerides. Hyperlipoproteinemia refers to raised lipoproteins, the particles that carry those lipids. Since lipids only travel inside lipoproteins, the two descriptions overlap almost completely.
The longer term survives partly from an older classification system that sorted lipid disorders by which lipoprotein class was elevated on testing. In that system, the combination of raised LDL and raised very low density lipoprotein, which is the particle class richest in triglycerides, sits in the category clinicians still sometimes call type IIb. A modern lab report is more likely to simply list the panel values and let the ordering clinician interpret the shape.
One caution worth holding onto. Different naming systems can make the same bloodwork look like several different findings across different reports, letters or portals. If a result carries an unfamiliar label, the useful question is not which word is correct but which specific numbers were elevated, by how much, and whether a repeat test showed the same thing.
It matters because the number of apolipoprotein B carrying particles in the bloodstream tracks closely with how much cholesterol can be deposited in artery walls over time, and a mixed pattern usually means more of those particles. Each particle carries a single apolipoprotein B, so a high count means many separate opportunities for cholesterol to enter the arterial wall.
The combination of raised triglycerides with low HDL cholesterol has its own name, atherogenic dyslipidemia, and it is studied in people already at elevated cardiovascular risk. Atherogenic dyslipidemia is associated with incident cardiovascular events in people at high risk who have hypertension 3. Research suggests that the same pattern contributes to residual vascular risk in people who have already had a stroke or transient ischaemic attack 4.
The inherited form carries its own signal. Research suggests that familial combined hyperlipidemia is associated with increased risk of coronary heart disease, which is part of why family history carries weight when a clinician interprets a mixed panel 5.
None of that translates into a prediction for any one person. Risk is cumulative and multifactorial, built from blood pressure, blood sugar handling, smoking status, age, sex, family history and the lipid numbers together. A mixed pattern raises the importance of the full assessment. It does not substitute for one, and it never means a specific outcome is on the way.
The pattern is read from the standard lipid panel, with triglycerides and at least one cholesterol measure sitting above their reference ranges at the same time. The table below shows typical lab reference ranges alongside FitScript's optimal range where one has been published for the marker.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Triglycerides | 30 to 150 mg/dL | 50 to 80 mg/dL |
| Total cholesterol | Under 200 mg/dL commonly reported as desirable | Not listed on this page |
| LDL cholesterol | Under 100 mg/dL commonly reported as optimal | Not listed on this page |
| HDL cholesterol | 40 mg/dL or above in men, 50 mg/dL or above in women | Not listed on this page |
| Non-HDL cholesterol | Under 130 mg/dL commonly reported as desirable | Not listed on this page |
| Apolipoprotein B | Varies by lab and assay, reported in mg/dL | Not listed on this page |
These are typical lab reference ranges and they vary by lab, age and sex, so the numbers printed on your own report are the ones that apply to your sample. The optimal range shown is FitScript's optimization target, not a diagnostic cut-off.
Two further points keep the table honest. First, no single row defines the pattern, because the whole idea of a mixed picture is that more than one value has moved. Second, values close to a cut-off are not meaningfully different from values just inside it. A triglyceride result of 152 mg/dL and one of 148 mg/dL describe the same biology, and a clinician reading a trend across several draws will treat them as such.
A panel with raised triglycerides and raised cholesterol can reflect inherited lipid biology, how the body is currently handling energy and insulin, another condition influencing lipid metabolism, or simply the circumstances of the blood draw. The observation is reliable. The explanation behind it is not contained in the panel.
Several contributors are worth a clinician's attention when this shape appears. Insulin resistance is a common one, because the way the body handles glucose and the way the liver packages triglycerides are tightly connected. Weight gain, particularly around the abdomen, shifts the same machinery. Alcohol intake in the days before a draw can move triglycerides substantially. Thyroid, kidney and liver function all influence lipid handling, and so do pregnancy and some medical conditions, which is why a first mixed panel often prompts a wider set of tests rather than an immediate conclusion.
The inherited possibility sits alongside all of these. A mixed panel in a lean, active person in their twenties or thirties, especially with relatives who had heart disease early, points a clinician's thinking in a different direction than the same panel in someone whose weight and blood sugar markers have been drifting for years.
The useful sequence is observation, then possible meaning, then conversation. The observation is that two lipid measures are outside the standard range on this sample. The possible meaning covers inherited biology, metabolic handling, another condition, or sampling conditions. The next step is a repeat test under comparable conditions and a review with a clinician who can see the rest of your history. A result outside the standard range is never something to ignore, and it is also not a diagnosis.
They move because triglycerides are genuinely variable, and because the inherited form of this pattern changes its appearance over time. Of all the routine lipid measures, triglycerides respond fastest to recent food, alcohol, illness, sleep loss and short term weight change, so two draws a fortnight apart can look quite different in the same person.
There is a second reason that is specific to the combined pattern. Studies indicate that the lipid phenotype in familial combined hyperlipidemia switches over time within the same person, so one panel may show mainly raised cholesterol, the next mainly raised triglycerides, and a third both together 6.
Two practical consequences follow. A single normal panel does not rule the pattern out in someone with a suggestive family history, and a single abnormal panel does not establish it either. Trends across repeated draws, taken under similar conditions, carry far more information than any one printout.
It also means comparing results is only fair when the circumstances match. Same fasting state, similar time of day, no acute illness, and ideally the same lab and assay, since reference ranges and methods differ between labs.
Sometimes it is, and the inherited form has a name, familial combined hyperlipidemia. It is the lipid disorder in which raised cholesterol, raised triglycerides or both appear across several members of the same family, with the specific pattern varying between relatives and over time in the same relative.
The genetics are not simple. Research suggests that familial combined hyperlipidemia reflects the combined effect of many genetic variants rather than a single gene defect, interacting with weight, diet and insulin sensitivity 7. Studies indicate that the underlying molecular picture centres on increased hepatic secretion of apolipoprotein B containing lipoproteins together with impaired clearance of triglyceride rich particles 1. Research suggests that polygenic risk scores, which sum the effect of many common variants, are being examined for their usefulness in identifying combined hyperlipidemia 8.
Because there is no single confirmatory gene test in routine use, diagnosis leans on pattern recognition. Research suggests that raised apolipoprotein B, a combined lipid picture, and evidence of lipid abnormalities in first degree relatives are the practical elements clinicians use when assessing for familial combined hyperlipidemia 6. Family history of early coronary disease strengthens the case, and research suggests that this condition is associated with increased coronary heart disease risk 5.
For a reader, the takeaway is modest and useful. If close relatives have had lipid problems or early heart disease, that information changes how a mixed panel should be interpreted, and it is worth bringing to the appointment. Whether any further testing or family screening makes sense is a clinician's call.
Atherogenic dyslipidemia is the specific triad of raised triglycerides, low HDL cholesterol and a predominance of small dense LDL particles, and it overlaps heavily with the mixed pattern without being identical to it. Mixed hyperlipidemia describes which lipid measures are elevated. Atherogenic dyslipidemia describes the particle quality that frequently accompanies those elevations.
The two terms get used interchangeably in conversation, which is understandable since they usually appear together. The distinction is still worth keeping. A person can have raised cholesterol and raised triglycerides with a reasonable HDL cholesterol value, and a person can have the triglyceride and HDL combination with a cholesterol value inside range. The particle level picture, best approximated by apolipoprotein B and non-HDL cholesterol, is what joins them.
On the management side, research suggests that nutrition has a central role in the prevention and management of atherogenic dyslipidemia 9. What that looks like for any individual, and whether anything beyond nutrition belongs in the picture, is a decision for a licensed provider who has reviewed the whole case.
The markers that add most are the ones that count particles, quantify metabolic context and rule other conditions in or out. A lipid panel alone describes the shape but rarely explains it.
For the lipid side, apolipoprotein B gives a direct count of atherogenic particles and non-HDL cholesterol gives the total cholesterol carried inside them, both of which stay informative when triglycerides are high and calculated LDL cholesterol becomes less reliable. Lipoprotein(a) is measured at least once in a lifetime for most adults, since it is largely genetically set and sits outside the standard panel.
For metabolic context, HbA1c and fasting glucose describe blood sugar handling over different time frames, and fasting insulin adds a view of how hard the body is working to keep glucose in range. Waist measurement and blood pressure belong in the same conversation even though neither comes from a tube of blood.
For other influences on lipid metabolism, thyroid function, liver enzymes and kidney markers are commonly checked, because a condition affecting any of those systems can shift lipids. An inflammation marker such as high sensitivity CRP is sometimes added to the risk picture.
The point of a wider panel is not more numbers for their own sake. It is that a mixed lipid pattern has several plausible explanations, and the surrounding markers are what narrow the list before any decision is made.
Testing is a standard venous blood draw analysed as a lipid panel, and fasting matters more for triglycerides than for any other value on the report. Total cholesterol, HDL cholesterol and apolipoprotein B change relatively little after a meal, while triglycerides can rise substantially for hours afterwards.
Many labs and guidelines now accept non-fasting samples for routine screening, and others still request a fast, commonly of around 9 to 12 hours of water only. The important thing is consistency. If the first panel was fasting and the follow up is not, part of any apparent change is the breakfast rather than the biology. Follow whatever instruction the ordering clinician or lab gives, and note the fasting state so the comparison stays fair.
A few other conditions affect the sample. Recent alcohol, an acute illness or infection, recent surgery, and significant short term weight change can all move lipids, and pregnancy shifts them in a predictable way. Clinicians usually wait for recovery from an acute illness before drawing lipids they intend to act on.
FitScript members have 150+ biomarkers tested per year, with results interpreted by Atlas, FitScript's AI health advisor, and any treatment decision made by a licensed provider who reviews the member first. Repeat testing over time is what turns a single snapshot into a trend, which is the form this particular pattern is best read in.
Read it as an observation that needs context, and leave the decision about next steps to a clinician who can see that context. The three step frame is simple. What the values show, what they may reflect, and what is worth raising at an appointment.
What they show is factual. Triglycerides sat at a given number on a given day, cholesterol measures sat at theirs, and the lab's reference ranges place some of those values outside the usual spread. What they may reflect is broader, covering inherited lipid biology, insulin resistance, another condition affecting lipid metabolism, or the conditions of the draw itself. What is worth raising includes family history of early heart disease, blood pressure, blood sugar markers, weight trend, alcohol intake, and whether the result has been repeated.
What a page like this cannot do is tell you what the numbers mean for you specifically. A mixed pattern in a 28 year old with a strong family history and a mixed pattern in a 58 year old with longstanding hypertension are the same two words describing two different clinical situations.
Decisions about next steps, including whether any therapy is appropriate, belong to a licensed provider who evaluates the full picture, not to a lab report or an article. This guide is educational and is not medical advice. Discuss your own results and any treatment with a clinician or licensed provider before acting on them.
Any lipid result outside the standard reference range is worth a conversation, and some situations warrant one sooner rather than later. Clinicians regard a markedly elevated triglyceride value, far above the top of the reference range, as something to review promptly rather than at the next routine visit.
Other situations that justify an earlier conversation include a close relative who had a heart attack or stroke at a young age, lipid abnormalities appearing across several family members, a mixed pattern appearing in someone young or lean, or lipid values that have shifted sharply from a previous panel without an obvious reason. A result alongside new symptoms such as chest discomfort, breathlessness on usual activity, or sudden weakness or speech difficulty is a reason for urgent medical attention rather than a scheduled appointment.
Bring the actual numbers, the fasting state, the dates of previous panels and the family history to the appointment. Those four things do more to shape the discussion than the label printed at the top of the report.
To go deeper on the individual markers that make up this pattern, see the guides to ldl cholesterol, apolipoprotein b and cholesterol non hdl.
No. High cholesterol usually means one measure is elevated, while mixed hyperlipidemia means cholesterol and triglycerides are both above their reference ranges in the same person. That two sided picture often changes which markers are most informative, so a clinician may look at apolipoprotein B and non-HDL cholesterol as well as LDL cholesterol.
It describes the same bloodwork, with the longer word pointing at the lipoprotein particles rather than the fats they carry. Since cholesterol and triglycerides only travel inside lipoproteins, the two terms overlap almost completely. If a report uses an unfamiliar label, ask which specific values were elevated and by how much.
It depends on what the ordering clinician or lab requests, since many labs now accept non-fasting samples for routine screening. Fasting matters most for triglycerides, which rise for hours after a meal. The practical rule is consistency, so compare panels taken in the same fasting state and note which state each sample was in.
No single panel settles it. Triglycerides in particular move with recent meals, alcohol, illness, sleep and short term weight change, so one result is a snapshot rather than a trend. Clinicians usually repeat the test under comparable conditions before drawing any conclusion about the pattern.
It can run in families, and the inherited version is called familial combined hyperlipidemia. There is no single routine gene test that confirms it, so clinicians assess the pattern of results across repeated panels alongside lipid results in close relatives. A family history of early heart attack or stroke is important information to bring to an appointment.
A standard lipid panel shows the pattern, and apolipoprotein B plus non-HDL cholesterol describe it more completely when triglycerides are high. Clinicians often add markers of blood sugar handling such as HbA1c and fasting glucose, along with thyroid, liver and kidney tests, to understand what sits behind the numbers.
Usually not. Lipid patterns are typically silent and found on a blood test ordered for screening or another reason, which is why periodic testing is how most people learn about them. Any new chest discomfort, breathlessness on usual activity, or sudden weakness or speech difficulty needs urgent medical attention regardless of what a lipid panel shows.
Any value outside the standard reference range is worth discussing, and a triglyceride result far above the top of the range is worth discussing promptly. Bring the actual numbers, the fasting state, the dates of earlier panels and your family history. A licensed provider decides whether repeat testing or anything further is appropriate.